Deployment and transcriptional evaluation of nitisinone, an FDA-approved drug, to control bed bugs
M. Sterkel, J. Tompkin, C. Schal, L. M. Guera, G. C. D. Pessoa, P. L. Oliveira, J. B. Benoit
This study evaluates nitisinone (NTBC) as a new treatment for bed bugs, showing it is lethal to both susceptible and resistant populations but with slight resistance in the latter, and identifies molecular mechanisms of action.
bioRxiv · Jun 18, 2024Physiology